ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Anxiety"

  • Abstract Number: 0250 • ACR Convergence 2022

    Performance of Fear Assessment in Inflammatory Rheumatic Diseases (FAIR) Questionnaire in a Cohort of Rheumatoid Arthritis Patients in Argentina

    Jose Simon Alcivar-Navarrete1, Joan Manuel Dapeña1, Juan Manuel Bande1, Eliana Rebeca Serrano1, Maria Alejandra Medina1, Diana Silvia Klajn1, Jose Angel Caracciolo1, Analia Dellepiane2, Maria Paula Kohan3, Maria Julia Sosa3, maria de los angeles correa4, Maximiliano Machado Escobar5, Maria Silvia Yacuzzi5, Debora Guaglianone6, Mariana Benegas7, Emel de Jesus Gonzalez Lobato8, Eduardo Kerzberg8, Sandra Petruzzeli9, Beverly De la Puente Perez10 and Silvia Beatriz Papasidero1, 1Hospital General de Agudos Dr. Enrique Tornu, Buenos Aires, Argentina, 2Centro de Especialidades Medicas Caseros, Casilda, Argentina, 3Hospital Dr. Raul F. Larcade, San Miguel, Buenos Aires, Argentina, 4Rheumatology Unit, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 5Hospital Eva Peron, Banda del Rio Sali, Argentina, 6Hospital Provincial de Rosario, Rosario, Santa Fe, Argentina, 7Sanatorio Dr. Julio Mendez, Buenos Aires, Argentina, 8Hospital General de Agudos Dr. Ramos Mejia, Buenos Aires, Argentina, 9Casa Hospital San Juan de Dios, Ramos Mejia, Buenos Aires, Argentina, 10Hospital General de Agudos Dr. Jose Maria Penna, Buenos Aires, Argentina

    Background/Purpose: RA is a systemic disease that can compromise many aspects of patient health. The increased psychological burden of RA is known and multifactorial, recent…
  • Abstract Number: 0390 • ACR Convergence 2022

    Persistent Post-Covid Symptoms in Psoriatic Arthritis Patients

    Sonia Pastor Navarro1, Marta Ibáñez Martínez1, Olga Compán Fernández1, Belén Miguel Ibáñez1, Olga Martínez González1, Cristina Hidalgo Calleja1, Ana Isabel Turrión Nieves1, Susana Gómez Castro2 and Carlos Montilla Morales1, 1Hospital Universitario de Salamanca, Salamanca, Spain, 2Hospital Universitario Salamanca, Salamanca, Spain

    Background/Purpose: Symptomatic onset long after recovery from the acute phase of COVID-19 infection has been reported by the population. Currently, it is not known how…
  • Abstract Number: 0119 • ACR Convergence 2021

    Worsened Depression but Improved Fatigue Were the Main Impacts of Severe Lockdown in Non- COVID Infected Australian Fibromyalgia Patients

    Benjamin Worcester1, Emma Guymer2 and Geoffrey Littlejohn2, 1Monash Health, Melbourne, Australia, 2Monash University, Melbourne, Australia

    Background/Purpose: To gauge the impact of severe COVID-19 related lockdown restrictions on the mental and physical wellbeing of Australian fibromyalgia patients and their recovery following…
  • Abstract Number: 0236 • ACR Convergence 2021

    Maternal Attachment, Anxiety and Depressive Symptoms in Pregnant Women with Rheumatic Diseases

    Luis Gerardo Espinosa-Banuelos1, Diana Carolina Rubio Torres2, Maria Corral2, Cassandra Skinner Taylor2, Lorena Perez-Barbosa2, Luz Fernanda Gutierrez Leal2, Abraham Yair Lujano-Negrete3, Jesus Cardenas-de La Garza2 and Dionicio Galarza-Delgado2, 1Faculty of Medicine and University Hospital Dr. Jose Eleuterio Gonzalez, UANL, Monterrey, Mexico, 2Hospital Universitario "Dr Jose E. Gonzalez", Monterrey, Mexico, 3Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico

    Background/Purpose: Untreated perinatal anxiety symptomatology can be related to symptoms of anxiety and depression during the postpartum. The psychological bond created by the mother between…
  • Abstract Number: 0308 • ACR Convergence 2021

    Sleep Disorders and Serum Brain-derived Neurotrophic Factor Levels in Patients with Primary Sjögren’s Syndrome

    Yaxin Han1, Li Long2, Xixi Chen2, Qing Peng2, GUO TANG3, Jiajun Liu2 and Yan Liu2, 1The People's Hospital of Wenjiang,China; Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China;Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China (People's Republic), 2Department of Rheumatology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China (People's Republic), 3Chongqing Bishan People's Hospital, Chongqing, China (People's Republic)

    Background/Purpose: This study aimed to evaluate the sleep quality and its influenced factors in patients with primary Sjögren's syndrome (pSS), and another purpose is to…
  • Abstract Number: 0476 • ACR Convergence 2021

    Factors Associated with Pain Reduction and Improved Well-Being Among Fibromyalgia Patients Using Medical Cannabis

    Marc Martel1, Lilach Eyal Waldman1, Romina Sotoodeh1, Antonio Vigano1, Yola Moride2, Michelle Canac-Marquis3, Rihab Gamaoun3, Maja Kalaba4, Pierre Beaulieu2, Julie Desroches2, Mark A. Ware4, Jordi Perez3, Yoram Shir3 and Mary-Ann Fitzcharles1, 1McGill University, Montréal, QC, Canada, 2Université de Montréal, Montréal, QC, Canada, 3McGill University Health Centre, Montréal, QC, Canada, 4Canopy Growth Corporation, Montréal, QC, Canada

    Background/Purpose: Fibromyalgia (FM) is characterized by a constellation of symptoms that are often poorly responsive to current treatments, and patients are increasingly turning to medical…
  • Abstract Number: 0725 • ACR Convergence 2021

    Efficacy of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Knee or Hip: A Post Hoc Subgroup Analysis of Patients from a Randomized, NSAID-Controlled Study with a History of Depression, Anxiety, or Insomnia

    Philip Mease1, Theresa Mallick-Searle2, Elizabeth Johnston3, Lars Viktrup3, Dominique Menuet4, Ruoyong Yang5 and Robert Fountaine6, 1Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, 2Stanford Health Care, Redwood City, 3Eli Lilly and Company, Indianapolis, IN, 4Pfizer SAS, Paris, France, 5Pfizer Inc., New York, NY, 6Pfizer Inc., Groton, CT

    Background/Purpose: Tanezumab is a monoclonal antibody directed against nerve growth factor that is under study to treat moderate to severe chronic pain associated with osteoarthritis…
  • Abstract Number: 0736 • ACR Convergence 2021

    Decrease in Prevalence of Self-Reported Anxiety or Depression in Persons with Osteoarthritis After Total Knee Arthroplasty: The BEST KNEE Cohort Study

    Owen Krystia, Lauren King, Esther Waugh and Gillian Hawker, University of Toronto, Toronto, ON, Canada

    Background/Purpose: While anxiety and depression are highly prevalent in persons with symptomatic knee osteoarthritis (OA), few studies have assessed the effect of treatment of knee…
  • Abstract Number: 0872 • ACR Convergence 2021

    Lack of Association Between Cognitive Test Performance and Cognitive Symptoms in Systemic Lupus Erythematosus (SLE)

    Sudha Raghunath1, Yifat Glikmann-Johnston1, Emma Guymer1, Eric Morand2, Julie Stout1 and Alberta Hoi3, 1Monash University, Melbourne, Australia, 2School of Clinical Sciences at Monash Health, Monash University Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre Clayton, Melbourne, Australia, 3Department of Rheumatology, Monash Health & Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia

    Background/Purpose: Cognitive dysfunction (CD) is reported to affect approximately 40% of SLE patients (1). Mood disorders have been associated with both cognitive symptoms and cognitive…
  • Abstract Number: 1590 • ACR Convergence 2021

    Sleep Disturbance Improves with SARS-COV2 Vaccinations in Patients with Rheumatologic and Chronic Inflammatory Diseases

    Niti Pawar1, Kimberly E. Taylor1, Monica Yang1, Parakkal Deepak2, Wooseob Kim2, Michael Paley3, Mehrdad Matloubian1, Alex Carividi1, Matthew Ciorba2, Emanuel Demissie1, Alia A. El-Qunni,2, Katherine Huang2, Baylee Kinnett2, Lily E. McMorrow2, Diana Paez1, Abbey Rose2, Rebecca E. Schriefer2, Ali H Ellebedy2, Alfred Kim2, Mary Nakamura4, Patricia Katz1 and Lianne Gensler5, 1University of California San Francisco, San Francisco, CA, 2Washington University School of Medicine, St. Louis, MO, 3Washington University in St. Louis, Olivette, MO, 4UCSF/SFVAHCS, San Francisco, CA, 5Department of Rheumatology, University of California San Francisco, San Francisco, CA

    Background/Purpose: As the COVID-19 pandemic unfolded, people across the world experienced a psychological burden with social confinement, concerns about health, potential infection, jobs, financial difficulty,…
  • Abstract Number: 1613 • ACR Convergence 2021

    Pandemic and Patients: Examining Health-Related Behaviors of Patients with Systemic Sclerosis During the COVID-19 Pandemic

    Nancy Dorr1, Patricia Fennell2 and Lee Shapiro3, 1The College of Saint Rose, Albany, NY, 2Albany Health Management Associates, Inc. Steffens Scleroderma Foundation, Albany, NY, 3Albany Medical College, Stillwater, NY

    Background/Purpose: Prior to COVID-19, few studies examined how patients with a chronic illness, such as systemic sclerosis (SSc), react to a pandemic. This study examined…
  • Abstract Number: 1672 • ACR Convergence 2021

    Many Better, Many Worse: Mean PROMIS-29 Scores Mask Significant Shifts During COVID-19 in RA

    Susan Bartlett1, Dana DiRenzo2, Michelle Jones3 and Clifton Bingham2, 1McGill University, Montréal, QC, Canada, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins Medicine, Baltimore, MD

    Background/Purpose: Rheumatic diseases (RD) are chronic conditions that require potent immunosuppressants to control systemic inflammation. Fears associated with increased vulnerability from being on immunosuppressants plus…
  • Abstract Number: 1673 • ACR Convergence 2021

    Riding Multiple Waves of Uncertainty: Real World Canadian RA Patient Outcomes over 1 Year of COVID-19 Restrictions

    Orit Schieir1, Susan Bartlett2, Marie-France Valois2, Louis Bessette3, Gilles Boire4, Glen Hazlewood5, Carol Hitchon6, Edward Keystone7, Janet Pope8, Diane Tin9, Carter Thorne10, Vivian Bykerk11 and CATCH Investigators12, 1Canadian Early Arthritis Cohort Study, Montréal, QC, Canada, 2McGill University, Montréal, QC, Canada, 3Centre de l'Ostoporose et de Rhumatologie de Qubec, Québec City, QC, Canada, 4Universite de Sherbrooke, Sherbrooke, QC, Canada, 5University of Calgary, Calgary, AB, Canada, 6University of Manitoba, Winnipeg, MB, Canada, 7Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 8University of Western Ontario, London, ON, Canada, 9The Arthritis Program Research Group, Newmarket, ON, Canada, 10Southlake Regional Health Centre, Newmarket, ON, Canada, 11Hospital for Special Surgery, New York, NY, 12Mt Sinai Hospital, Toronto, ON, Canada

    Background/Purpose: During the COVID-19 pandemic, Canadians adults with RA faced considerable uncertainty due to greater risk of infection, hospitalization, changing access to RA medications, and…
  • Abstract Number: PP01 • ACR Convergence 2021

    Unicycling for a Cure: My UNIque Physical Activity Intervention for Rheumatoid Arthritis During the COVID19 Pandemic

    Dana Guglielmo, San Diego, CA

    Background/Purpose: I was diagnosed with rheumatoid arthritis at age 17. In my 20s, I joined Racing For A Cure of the Arthritis National Research Foundation,…
  • Abstract Number: 1947 • ACR Convergence 2020

    Risk Factors for Anxiety and Depression in Patients with Giant Cell Arteritis

    Joana Martinho1, André Ponte2, Eduardo Dourado3, Nikita Khmelinskii1, Sara Dias4, Sofia Barreira5, Ana Rita Cruz-Machado1, Carla Macieira1, Vítor Teixeira6, Ana Rodrigues4, Diogo Telles-Correia7, João Eurico Fonseca8 and Cristina Ponte1, 1Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 2Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal, Lisbon, Portugal, 3Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Lisboa, Portugal, 4EpiDoC Unit, Centro de Estudos de Doenças Crónicas (CEDOC), NOVA Medical School, Universidade NOVA de Lisboa (NMS/UNL), Lisbon, Portugal, 5Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal, 6Rheumatology Department, Centro Hospitalar Universitário do Algarve, Faro, Portugal, 7Serviço de Psiquiatria, Hospital de Santa Maria, CHULN, Lisboa, Portugal, Lisbon, Portugal, 8Instituto de Medicina Molecular, Faculdade Medicina Universidade de Lisboa and Centro Hospitalar Universitário Lisboa Norte., Lisboa, Portugal

    Background/Purpose: Giant cell arteritis (GCA) is the most common primary vasculitis affecting patients aged above 50 years. Its clinical manifestations such as headache, jaw claudication…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology